CEACAM5 and cancer: When directly comparing the cytotoxic effects of Cibisatamab across cancer spheroids and healthy organoids, we observed a clear trend of specific lysis in CEAhigh MKN-45 cancer spheroids and rectal organoids with intermediate CEA expression, while sparing DLD-1 spheroids and small intestinal organoids with lower CEA levels.